Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-569-5 | CAS number: 108-29-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity
Treatment of rats and rabbits with different doses of the test item resulted in a LD50(rat) of 8.8 mL/kg bw (9249 mg/kg bw) and a LD50(rabbit) of 2.48 mL/kg bw (2606 mg/kg bw).
Acute inhalation toxicity
In studies with rats, mice and rabbits the LC50 was highter than 10000 mg/m³ after exposure with different concentrations of test item vapors and aerosols.
Acute dermal toxicity
In a study with rabbits, 2 mL/kg bw (2102 mg/kg bw) of the test item did not induce irritation or damage to the skin of 6 rabbits. The LD50 was thus found to be >2102 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not available, publication received 1945-05-31
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: The purpose of this investigation was to determine the immediate toxicity of the test item by oral administration to rats and its effects upon respiration and blood pressure.
- Short description of test conditions: Rats were treated with different volumes of the test item by gavage. No details about sex, environmental conditions or time schedule of the experiment are given.
- Parameters analysed / observed: Clinical signs, blood pressure and mortality - GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- No details given.
- Species:
- rat
- Strain:
- Wistar
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- IN-LIFE DATES: At least 36 hours
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED:
16 mL/kg bw - Doses:
- 4.7, 7.0, 10.0, 16.0 mL/kg bw
- No. of animals per sex per dose:
- 10 animals per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 36 hours
- Necropsy of survivors performed: No
- Clinical signs: Locomotor system, state of consciousness, respiration
- Other examinations: Blood pressure was recorded by means of a kymograph - Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 9 249 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Effect level was converted from 8.8 mL/kg bw to 9249 mg/kg bw
- Mortality:
- 10% mortality at 4.7 mL/kg bw (survival time 36 hours), 20% mortality at 7.0 mL/kg bw (survival time 10-14 hours), 70% mortality at 10 mL/kg bw (survival time 1-6 hours), 90% mortality at 16 mL/kg bw (survival time 35 min to 12 hours)
- Clinical signs:
- other: Clinical signs were marked muscular weakness, mild anesthesia, increase in the rate of respiration, followed by dyspnea and occasionally by mild asphyxial convulsions. Death resulted from combined effects of circulatory and respiratory failure.
- Gross pathology:
- No information given
- Other findings:
- No information given
- Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 9 249 mg/kg bw
- Quality of whole database:
- Study well documented, meets generally accepted scientific principles, acceptable for assessment
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- Not available, publication received 1945-05-31
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: The purpose of this investigation was to determine the effects resulting from the inhalation of an atmosphere saturated with the vapor and containing in addition droplets of the compound in the form of a mist.
- Short description of test conditions: Rats were exposed to a mixture of vapor and mist of the test item in air for 7 hours daily for several days. No details about sex, environmental conditions or MMAD/GSD are given.
- Parameters analysed / observed: Clinical signs and body weights - GLP compliance:
- not specified
- Test type:
- traditional method
- Limit test:
- no
- Specific details on test material used for the study:
- No details given
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- IN-LIFE DATES: From day 0 to day 4 (1st experiment), from day 0 up to day 92 (2nd experiment)
- Route of administration:
- inhalation: mixture of vapour and aerosol / mist
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Air was passed through a tower containing calcium chloride, the air flow is then measured by a rotameter, the air was further passed over the test item heated in a volatilizer and finally into the exposure chamber.
- Exposure chamber volume: 388 Liter
- Method of holding animals in test chamber: In cages
- Source and rate of air: 15 Liters per minute
- Method of conditioning air: Heating and volatilizing of the test item
- Treatment of exhaust air: The air was expelled from the cage through stack opening under a hood.
- Temperature in air chamber: 24-28°C
TEST ATMOSPHERE
- Brief description of analytical method and equipment used: Air samples were mixed with ethyl alcohol. A saturated solution of hydroxylamine hydrochloride (~7%) in 95% ethyl alcohol was added, followed by a 20% KOH solution. The mixture was heated and cooled down. afterwards HCl was added. The transmission of light at 490 µm of the solution was compared with those of water in a photoelectric colorimeter.
- Samples taken from breathing zone: No - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 7 h
- Remarks on duration:
- 1st experiment: 7 hours exposure/day for 4 successive days
2nd experiment: 7 hours exposure/day on successive days (Saturdays and Sundays excepted). Those that survived were so exposed on 60 days over a total period of 92 days. - Concentrations:
- Between 3 and 10 mg/L (1st experiment) and approx. 1.5 mg/L (2nd experiment)
- No. of animals per sex per dose:
- 1st experiment: 4 rats
2nd experiment: 4 rats - Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 4 days (1st experiment), upt to 92 days (2nd experiment)
- Necropsy of survivors performed: No
- Examinations performed: Clinical signs, body weight - Statistics:
- No statistics available
- Key result
- Sex:
- not specified
- Dose descriptor:
- LC50
- Effect level:
- > 10 000 mg/m³ air
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- 1st experiment: No mortality
2nd experiment: No mortality - Body weight:
- No information given
- Gross pathology:
- No information given
- Other findings:
- 1st experiment: No signs of illness
2nd experiment: No signs of illness - Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- > 10 000 ca. mg/m³ air
- Physical form:
- inhalation: mixture of vapour and aerosol / mist
- Quality of whole database:
- Study well documented, meets generally accepted scientific principles, acceptable for assessment
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not available, publication received 1945-05-31
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: The purpose of this investigation was to determine the effects resulting from its application upon the skin.
- Short description of test conditions: The test substance was applied to the shaved belly of rabbits for 2 hours, the procedure was repeated on several days. No details about sex, environmental and treatment are given.
- Parameters analysed / observed: Local and systemic illness, body weights - GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- No information available.
- Species:
- rabbit
- Strain:
- other: Albino rabbits
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Albino rabbits were purchased from a local breeder
- Acclimation period: About 2 weeks
IN-LIFE DATES: From day 0 to day 45 - Type of coverage:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- REMOVAL OF TEST SUBSTANCE
- Washing: The test item was washed off the skin with soap and water
- Time after start of exposure: 2 hours
TEST MATERIAL
- Amount applied: 2 mL/kg bw
- Constant volume or concentration used: No
- For solids, paste formed: No - Duration of exposure:
- 2 hours per exposure, exposure for 33 days over a period of 45 days
- Doses:
- 2 mL/kg bw
- No. of animals per sex per dose:
- 6 animals per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: Animals were exposed and observed over a period of 45 days.
- Frequency of weighing: At the beginning and end of the exposure period
- Necropsy of survivors performed: No
- Examinations performed: Clinical signs, body weight - Statistics:
- No statistics performed
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 2 102 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Remarks:
- Effect level was converted from 2 mL/kg bw to 2102 mg/kg bw
- Mortality:
- No mortality occured
- Clinical signs:
- other: None of the animals displayed signs of local or systemic illness. The compound did not produce irritation or damage to the skin of these animals.
- Gross pathology:
- No gross pathology was performed.
- Other findings:
- No other findings were observed.
- Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- > 2 102 mg/kg bw
Additional information
Acute oral toxicity, rat, RL2
In an acute oral toxicity study in rats, 10 animals per dose were treated with the test item by gavage. Doses of 4.7, 7.0, 10.0 and 16.0 mL/kg bw were used. Oral doses of the test item were given to the rats by means of a blunt hypodermic needle. The test item induced dose-dependent effects comprising muscular weakness, mild anesthesia and an increase in the rate of respiration. These signs were followed by dyspnea and by mild asphyxial convulsions. Death resulted from the combined effects of circulatory and respiratory failure. The lethal quantity given orally in one dose at which 50% of the animals died was 8.8 mL/kg bw, corresponding to 9249 mg/kg bw (Deichmann, 1945).
Acute oral toxicity, rabbit, RL2
In an acute oral toxicity study in rabbits, 10 animals per dose were treated with the test item by gavage. Doses of 0.94, 1.4, 2.1, 3.2, 4.7 and 7.0 mL/kg bw were used. Oral doses of the test item were given to rabbits by means of a rubber catheter. The test item induced dose-dependent effects comprising muscular weakness, mild anesthesia and an increase in the rate of respiration. These signs were followed by dyspnea and by mild asphyxial convulsions. Death resulted from the combined effects of circulatory and respiratory failure. The lethal quantity given orally in one dose at which 50% of the animals died was 2.48 mL/kg bw, corresponding to 2606 mg/kg bw (Deichmann, 1945).
Acute oral toxicity, rabbit, RL4
In an acute oral toxicity study in rabbits, the LD50 was reported to exceed 5000 mg/kg bw. No further details were given (Opdyke, 1962-1980; based on the original study of Moreno, 1978).
Acute oral toxicity, rat, RL4
In an acute oral toxicity study in rats, the LD50 was reported to be 9200 mg/kg bw. No further details were given (Baer&Griepentrog, 1966).
Acute inhalation toxicity, mouse, RL2
In an acute inhalation toxicity study, 4 mice (1st experiment) and another 6 mice (2nd experiment) were treated with 3-10 mg/L air of the test item (1st experiment) or with approx. 1.5 mg/L air of the test item (2nd experiment). Mice developed systemic illness after acute treatment with 1.5 - 10 mg/L air, comprising signs of respiratory disturbance. After longer treatment with 3-10 mg/L of the test item, one mice showed a complete paralysis of the hind quarters. One mouse died after the first exposure to 3-10 mg/L air. As only 1/4 mice died after acute exposure, no LC50 could be determined (Deichmann, 1945).
Acute inhalation toxicity, rat, RL2
In an acute inhalation toxicity study, 4 rats (1st experiment) and another 4 rats (2nd experiment) were treated with 3-10 mg/L air of the test item (1st experiment) or with approx. 1.5 mg/L air of the test item (2nd experiment). Rats showed no signs of illness after exposure to 1.5-10 mg/L of the test item for up to 60 seven-hour periods. No LC50 could be determined (Deichmann, 1945).
Acute inhalation toxicity, rabbit, RL2
In an acute inhalation toxicity study, 2 rabbits (1st experiment) and another 2 rabbits (2nd experiment) were treated with 3-10 mg/L air of the test item (1st experiment) or with approx. 1.5 mg/L air of the test item (2nd experiment). Rabbits showed no signs of illness after exposure to 1.5-10 mg/L of the test item for up to 60 seven-hour periods. No LC50 could be determined (Deichmann, 1945).
Acute dermal toxicity, rabbit, RL2
In an acute dermal toxicity study in rabbits, 6 animals were treated with 2 mL/kg bw. Therefore, the hair on the belly was clipped short over an area of about 20 square inches. After application, animals were kept under mild restraint for 2 hours. The compound was then washed off with soap and water and the animal returned to their cages. Applications were given daily, except sundays for 45 days. None of the animals displayed signs of local or systemic illness. The compound does not produce irritation or damage to the skin of the animals. The LD50 was thus found to be >2102 mg/kg bw (Deichmann, 1945).
Acute dermal toxicity, rabbit, RL4
In an acute dermal toxicity study in rabbits, the LD50 was reported to exceed 5000 mg/kg bw. No further details were given (Opdyke 1962-1980, based on the original study of Moreno, 1978).
Acute i.m. toxicity, guinea pig, RL4
Different organic esters were examined for systemic toxicity, local irritation and action upon the neuro-muscular functions after intramuscular injection in the guinea pig's leg. A single dose of 2.5 cc./kg bw (2.5 mL/kg bw) of the test item was injected i.m. and animals were observed for one week. 75% of the animals died within 2 days (Lipschitz, 1942).
Acute i.p. toxicity, mouse, RL2
In an acute oral toxicity study, small groups of mice were injected intraperitoneally with increasing dosage levels of the test item and the resulting mortality was recorded for one week. The approximate LD50 (7-day) was used as the basis for selecting the dosage levels for a radioprotectivity study. The LD50 of the test item was found to be higher than 500 mg/kg bw (Doull, 1962).
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. The LD50 was greater than 2000 mg/kg bw for both acute oral and dermal toxicity and the LC50 was greater than 3000-10000 mg/m³ air. As a result, the substance is not considered to be classified for acute oral, inhalation and dermal toxicity under Regulation (EC) No 1272/2008, as amended for fifteenth time in Regulation (EU) No 2020/217.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.